Commercialization: Page 23

PharmaVoice Team/PharmaVoice

Patients and Regulatory Support

Regulators are working to make sure patients have a seat at the clinical trial table. The Food and Drug Administration has been instrumental in the movement toward patient-centric clinical trial initiatives and driving these initiatives forward is the future of trial development. In recent years,...
By Denise Myshko • April 1, 2019
PharmaVoice Team/PharmaVoice

The Caregiver Gap

Caregivers are often an integral part of the care team and are involved in everything from medication choice to adherence. Caregivers are significant players in the healthcare ecosystem and, for many individuals, a necessary part of managing an illness or chronic condition. Caregivers provide an ...
By Denise Myshko • April 1, 2019
PharmaVoice Team/PharmaVoice

SHOWCASE: Brand Building: Brand Awareness in a Patient-Centric Era

Today, pharmaceuticals, biotech products, and other treatments are part of a broader approach to healthcare that encompasses preventative tools, wellness, and patient or consumer preference. The pharmaceutical industry no longer exists in a silo. How companies build their brands and brand awarene...
By PharmaVoice Team • March 1, 2019
PharmaVoice Team/PharmaVoice

Once Upon A Time in Marketing

Have you noticed how many “storytellers" there are in our industry today? Just do a search on LinkedIn. There are brand and strategy storytellers. Heads of digital storytelling. Storytellers-in-chief. Seemingly legions of people in the business of storytelling. You could certainly dismiss it as a...
By Lou Iovino • March 1, 2019
PharmaVoice Team/PharmaVoice

Customer-Centric Brand Building

The pharmaceutical company landscape is transforming. With this evolution, brand portfolios range from mass production of products for chronic diseases affecting large portions of populations, to development of novel treatments for rare diseases and personalized medicine. Today, we have the domin...
By Brandie Linfante • March 1, 2019
PharmaVoice Team/PharmaVoice

People + Purpose + Progress: Making Healthcare Brands More Relevant in Today's Changing Market

My favorite definition of a brand is the one that goes “a brand is something that lives between your ears." A more tangible description comes from author James Gregory who says, “a brand is the sum total of all the images, ideas, and experiences associated with that brand." So when we ask ourselv...
By Johanna Skilling • March 1, 2019
PharmaVoice Team/PharmaVoice

Customer Co-Creation: Engaging and Activating Advisors

Leveraging Design Thinking to Uncover Better Real World Solutions in Advisory Boards Traditional Advisory Boards are Broken These are real quotes we have collected from colleagues and clients across the life sciences industry over the past few years. The idea of engaging customers to better under...
By Drew Beck • March 1, 2019
PharmaVoice Team/PharmaVoice

The Big Deal About Small Data

Big data gets all the hype, but the power of small data cannot be overlooked. Small data is mighty. Small data is small enough for human comprehension, in a volume and format that are accessible, informative, and actionable. Certainly, big data has gotten a lot of hype over the past few years, bu...
By Robin Robinson • March 1, 2019
PharmaVoice Team/PharmaVoice

Picture Perfect: Instagram's Place in Pharmaceutical Engagement

Instagram is a robust social media forum with more than 1 billion monthly active users, but success depends on understanding how to harness its visual power. What do photo sharing and the pharmaceutical industry have in common? The answer is a lot more than you might expect. Instagram has become ...
By Kim Ribbink • March 1, 2019
PharmaVoice Team/PharmaVoice

Executive Perspective: A New Beginning: The Future of Global Communications

When two veteran healthcare advertising executives decide to rejoin forces, the natural — and expected — assumption is that they would launch a new, differentiated, potentially funky, boutique-type communications agency. Well, Matt Giegerich and Shaun Urban are doing anything but the expected. Th...
By Matt Giegerich • March 1, 2019
PharmaVoice Team/PharmaVoice

Upfront

Bayer Ups its Pledge for Science Learning Experiments For Children Bayer has pledged 5 million hands-on science learning experiments for children in the United States by 2025. The milestone, if achieved, will correspond with the 30th anniversary of Bayer’s award-winning commitment to science, tec...
By PharmaVoice Team • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Health Tech

POPS! Blood Glucose Test Attaches To Smartphone Trend Watch: Medical Devices Support Patient Monitoring from Head to Toe Minneapolis-based POPS! Diabetes Care received FDA clearance for its blood glucose monitoring system that can be adhered to the back of a smartphone. Readings are taken via bui...
By PharmaVoice Team • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Transformation: Ready, Set, Agile

According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of nex...
By PharmaVoice Team • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

SHOWCASE: Outsourcing - M&A on the Rise

Pharmaceutical outsourcing remains big business, as companies cut internal costs and with the rise of smaller specialist companies focused on rare diseases and genomics-based therapies. The move to outsource is growing, with reports that companies are turning to partners more now than they did fi...
By PharmaVoice Team • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Outsourcing Regulatory Filings with an FTE Model: Five Keys to Consider

As an increasing number of drug and device developers focus their efforts on reducing costs so they can invest more heavily in their core R&D functions, it’s no surprise that the outsourcing market for healthcare regulatory affairs is predicted to expand at a rapid pace over the next decade. ...
By Clareece West • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

SHOWCASE: Rare Disease: Rare Difficulties: Finding Cures and Tackling Costs

The day-to-day lives of people with rare diseases is often poorly understood. And those with rare diseases face many challenges. Whether it’s going to work or studying, completing daily tasks such as preparing meals and shopping, or simply managing their health, the impact disease has on patients...
By PharmaVoice Team • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Raising One Voice for the Millions Impacted by Rare Disease

Next-generation technologies in medicine have opened new doors for identifying rare diseases and developing better and more targeted rare disease treatments. Remarkable advancements in global research efforts have already made an impact on the lives of patients living with hundreds of rare diseas...
By Meredith Gartner • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Is the Rare Disease Business Model Here to Stay?

These days, the term “rare disease" is well ingrained in our everyday vernacular — but that hasn’t always been the case. The pharmaceutical industry paid little attention to developing new treatments for rare disease prior to the Reagan Administration’s implementation of the Orphan Drug Act (ODA)...
By Scott D. Hibbard • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

From Scientific Discovery to Real World Application: the "Future" of Medicine is Here

I vividly remember the day in February of 2001 when the nearly complete sequence of the human genome was first published. My cellular and molecular biology professor had unfolded a giant poster from the journal Nature and revealed those approximately 30,000 genes to our class. Amazingly, in less ...
By Jahda Hill • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Executive Perspective: A Fused Model for the Enterprise - A Conversation with Brian Williams

Winning in today’s digital era requires more than just apps and a website. Fusing an enterprise for success in the digital era requires companies to seamlessly collaborate across the enterprise and create a true strategic pathway for a better customer experience. Recently, Cognizant commissioned ...
By Brian Williams • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Red Zone: Disruptive Innovation: Questions for the C-Suite

It is not the strongest of the species that survives, nor is it the most intelligent. It is the one that is most adaptable to change. Whether a direct quote from Charles Darwin or a summary of his writings, this statement is perhaps the most profound scientific explanation of life itself, in all ...
By Srini Shankar • Feb. 1, 2019
PharmaVoice Team/PharmaVoice

Letter from the Editor

Artificial Intelligence Happy New Year. As we enter 2019, we take note of one of the major trends expected to impact all aspects of the life-sciences industry: artificial intelligence. In 2019, according to Forrester, AI solutions will continue to spread across the healthcare continuum thanks to ...
By Taren Grom • Jan. 1, 2019
PharmaVoice Team/PharmaVoice

Upfront

Medicinal Theater BioMarin Pharmaceutical and Believe Ltd. sponsored a first-of-its-kind theatrical production for teenagers with hemophilia. The musical, Hemophilia: The Musical, took place at New World Stages on Nov. 12, 2018. Before the performance, students participated in the Breaking Throug...
By PharmaVoice Team • Jan. 1, 2019
PharmaVoice Team/PharmaVoice

HealthTech

Payers Use Healthtech to Improve Patient Outcomes, Lower Costs Trend Watch: Healthtech Mobile App Market Continues To Grow Payers Offer Free Wearables UnitedHealthcare, Aetna, and John Hancock have all implemented programs that offer free Apple Watches to customers, if they exercise daily. The la...
By PharmaVoice Team • Jan. 1, 2019
PharmaVoice Team/PharmaVoice

Artificial Intelligence

Artificial Intelligence Key to Improving Healthcare Quality, Reducing Costs Trend Watch: AI Implications for Healthcare are Widespread Artificial Intelligence (AI) is key to building a better healthcare future, according to a recent survey of 500 U.S. healthcare leaders on their attitudes and usa...
By PharmaVoice Team • Jan. 1, 2019